Zhuoqi C. Zhang
99#, Huaihai West Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction.
Journal: BMC cardiovascular disorders
Published: February 06, 2025
Early prediction of microvascular obstruction prior to percutaneous coronary intervention.
Journal: Scientific reports
Published: December 04, 2024
Predictive value of lymphocyte-to-C-reactive protein ratio for left ventricular thrombus in patients with ST-segment elevation myocardial infarction.
Journal: Frontiers in cardiovascular medicine
Published: August 09, 2024
Association between cardiac magnetic resonance ventricular strain and left ventricular thrombus in patients with ST-segment elevation myocardial infarction.
Journal: The international journal of cardiovascular imaging
Published: December 08, 2023
Internationalization of medical education in China: An investigation of medical graduates' global competence and its influencing factors.
Journal: Medical teacher
Published: October 25, 2023
The complexing of cationic copolymer MPC30-DEA70 with TGF-β1 antisense oligodeoxynucleotide and transfection into cardiomyocytes in vitro.
Journal: Journal of biomaterials applications
Published: November 14, 2022
Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway.
Journal: Stem cell research & therapy
Published: October 08, 2021
A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice.
Journal: Biomaterials science
Published: October 06, 2021
MiR-135a Protects against Myocardial Injury by Targeting TLR4.
Journal: Chemical & pharmaceutical bulletin
Published: June 03, 2021
Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a.
Journal: Frontiers in pharmacology
Published: November 23, 2020
MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway.
Journal: Stem cell research & therapy
Published: November 03, 2020
pH-Responsive and Biodegradable ZnO-Capped Mesoporous Silica Composite Nanoparticles for Drug Delivery.
Journal: Materials (Basel, Switzerland)
Published: July 14, 2020
Last Updated: 09/26/2026